Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on December 21, 2015. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pentostam

Closed
200-2016-Q-64608Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

1600 Clifton Road Bldg 23, Room 6-162, MS D09, ATLANTA, GA, 30329-4018, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Evelyn BradleyContract Specialist (CTR)
Lawrence R. McCoyContracting Officer

Full Description

Show more
This announcement is for informational purposes only. The Centers for Disease Control and Prevention (CDC), International Contracts Branch, Atlanta, GA, intends to award, on a sole source basis, firm fixed-price purchase order to GLAXOSMITHKLINE, LLC for the purchase of Pentostam for distribution by the CDC. This requirement is for supplies for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c) (1). Interested parties may identify their interests and capabilities to respond to the requirement or submit proposals. This is a notice of intent and not a request for proposals. The vendor is the only manufacturer whose product is approved by the FDA for treatment of leishmaniasis patients in the U.S. and no other source will meet the needs of the Government. This procurement will be processed under the authority of FAR 6.302-1. Only one responsible source and no other supplies or services will satisfy agency requirements. Interested persons may identify their interest and capability when responding to this notice. A determination by the Government not to compete the proposed requirement based on responses to this notice is solely within the discretion of the Government. The NAICS Code is 325412. This notice is not a request for competitive proposals. Information furnished shall include enough detailed information to allow the government to perform a proper evaluation. Respondents will not be notified of the evaluation results. Responses by Facsimile (Fax) will not be accepted. All vendors/prospective contractors must be registered with the System for Award Management (SAM) (www.sam.gov) prior to award date. Inquiries or proposals received more than 15 days after the date of this announcement will not be considered. Inquiries may be sent to the attention of the Contract Specialist, E. Bradley (CTR) at EBradley2@cdc.gov. If the Contract Specialist is not available, please contact the Contracting Officer, Lawrence McCoy at lmccoy1@cdc.gov

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS